Search Results - "van Dijk, Nick"

The Tumor Immune Landscape and Architecture of Tertiary Lymphoid Structures in Urothelial Cancer by van Dijk, Nick, Gil-Jimenez, Alberto, Silina, Karina, van Montfoort, Maurits L, Einerhand, Sarah, Jonkman, Lars, Voskuilen, Charlotte S, Peters, Dennis, Sanders, Joyce, Lubeck, Yoni, Broeks, Annegien, Hooijberg, Erik, Vis, Daniel J, van den Broek, Maries, Wessels, Lodewyk F A, van Rhijn, Bas W G, van der Heijden, Michiel S

“…Candidate immune biomarkers have been proposed for predicting response to immunotherapy in urothelial cancer (UC). Yet, these biomarkers are imperfect and lack…”
Get full text

Translation and validation of the Dutch version of the Oxford 12-item knee questionnaire for knee arthroplasty by Haverkamp, Daniël, Breugem, Stefan J M, Sierevelt, Inger N, Blankevoort, Leendert, van Dijk, C Nick

“…In 1998, the Oxford 12-item knee questionnnaire was developed by Dawson et al. as a self-administered disease- and site-specific questionnaire, specifically…”
Get more information

Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial by van Dijk, Nick, Gil-Jimenez, Alberto, Silina, Karina, Hendricksen, Kees, Smit, Laura A., de Feijter, Jeantine M., van Montfoort, Maurits L., van Rooijen, Charlotte, Peters, Dennis, Broeks, Annegien, van der Poel, Henk G., Bruining, Annemarie, Lubeck, Yoni, Sikorska, Karolina, Boellaard, Thierry N., Kvistborg, Pia, Vis, Daniel J., Hooijberg, Erik, Schumacher, Ton N., van den Broek, Maries, Wessels, Lodewyk F. A., Blank, Christian U., van Rhijn, Bas W., van der Heijden, Michiel S.

“…Preoperative immunotherapy with anti-PD1 plus anti-CTLA4 antibodies has shown remarkable pathological responses in melanoma 1 and colorectal cancer 2 . In…”
Get full text

The Cancer Immunogram as a Framework for Personalized Immunotherapy in Urothelial Cancer by van Dijk, Nick, Funt, Samuel A., Blank, Christian U., Powles, Thomas, Rosenberg, Jonathan E., van der Heijden, Michiel S.

“…The abysmal outlook of urothelial cancer (UC) has changed with the introduction of immunotherapy. Still, many patients do not respond and distinctive…”
Get full text

Response Rate to Chemotherapy After Immune Checkpoint Inhibition in Metastatic Urothelial Cancer by Szabados, Bernadett, van Dijk, Nick, Tang, Yen Zhi, van der Heijden, Michiel S., Wimalasingham, Akhila, Gomez de Liano, Alfonso, Chowdhury, Simon, Hughes, Simon, Rudman, Sarah, Linch, Mark, Powles, Thomas

“…Immune checkpoint inhibitors (ICIs) are active in metastatic urothelial carcinoma (MUC). They have joined chemotherapy (CT) as a standard of care. Here, we…”
Get full text

Clinical outcome after progressing to frontline and second-line Anti–PD-1/PD-L1 in advanced urothelial cancer by Gómez de Liaño Lista, Alfonso, van Dijk, Nick, de Velasco Oria de Rueda, Guillermo, Necchi, Andrea, Lavaud, Pernelle, Morales-Barrera, Rafael, Alonso Gordoa, Teresa, Maroto, Pablo, Ravaud, Alain, Durán, Ignacio, Szabados, Bernadett, Castellano, Daniel, Giannatempo, Patrizia, Loriot, Yohann, Carles, Joan, Anguera Palacios, Georgia, Lefort, Felix, Raggi, Daniele, Gross Goupil, Marine, Powles, Thomas, Van der Heijden, Michiel S.

“…Immune checkpoint inhibitors (ICIs) are approved for first-line (cisplatin unfit, PD-L1+) and platinum-refractory urothelial carcinoma (UC). Still, most…”
Get full text

Reply to: Comments on “Neoadjuvant/induction combination immunotherapy vs combination platinum‐based chemotherapy for locally advanced (Stage III) urothelial cancer” by Einerhand, Sarah M. H., Dijk, Nick, Heijden, Michiel S., Rhijn, Bas W. G.

Get full text

Survival after neoadjuvant/induction combination immunotherapy vs combination platinum‐based chemotherapy for locally advanced (Stage III) urothelial cancer by Einerhand, Sarah M. H., Dijk, Nick, Dorp, Jeroen, Feijter, Jeantine M., Montfoort, Maurits L., Kamp, Maaike W., Schaake, Eva E., Boellaard, Thierry N., Hendricksen, Kees, Heijden, Michiel S., Rhijn, Bas W. G.

“…Despite treatment with cisplatin‐based chemotherapy and surgical resection, clinical outcomes of patients with locally advanced urothelial carcinoma (UC)…”
Get full text

Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer by Pagliarulo, Fabio, Cheng, Phil F, Brugger, Laurin, van Dijk, Nick, van den Heijden, Michiel, Levesque, Mitchell P, Silina, Karina, van den Broek, Maries

“…Lymphoid neogenesis gives rise to tertiary lymphoid structures (TLS) in the periphery of multiple cancer types including muscle invasive bladder cancer (MIBC)…”
Get full text

Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors by Gil-Jimenez, Alberto, van Dijk, Nick, Vos, Joris L., Lubeck, Yoni, van Montfoort, Maurits L., Peters, Dennis, Hooijberg, Erik, Broeks, Annegien, Zuur, Charlotte L., van Rhijn, Bas W. G., Vis, Daniel J., van der Heijden, Michiel S., Wessels, Lodewyk F. A.

“…Immune checkpoint inhibitors (ICI) can achieve remarkable responses in urothelial cancer (UC), which may depend on tumor microenvironment (TME)…”
Get full text

On the Stability of Pt‐Based Catalysts in HBr/Br2 Solution by Liu, Qiang, Meissel, Hubert, Sadykov, Ilia, Jones, Simon, Van Dijk, Nick, Rzepka, Przemyslaw, Artiglia, Luca, Ranocchiari, Marco, Bokhoven, Jeroen A.

“…Stability studies on supported metal nanoparticles are essential for gaining insight into the design and optimization of high‐performance materials. In this…”
Get full text

Reclaimed and Up‐Cycled Cathodes for Lithium‐Ion Batteries by Gastol, Dominika, Marshall, Jean, Cooper, Elizabeth, Mitchell, Claire, Burnett, David, Song, Tengfei, Sommerville, Roberto, Middleton, Bethany, Crozier, Mickey, Smith, Robert, Haig, Sam, McElroy, Con Robert, Dijk, Nick, Croft, Paul, Goodship, Vannessa, Kendrick, Emma

“…As electric vehicles become more widely used, there is a higher demand for lithium‐ion batteries (LIBs) and hence a greater incentive to find better ways to…”
Get full text

Development of a Prognostic AI-Monitor for Metastatic Urothelial Cancer Patients Receiving Immunotherapy by Trebeschi, Stefano, Bodalal, Zuhir, van Dijk, Nick, Boellaard, Thierry N, Apfaltrer, Paul, Tareco Bucho, Teresa M, Nguyen-Kim, Thi Dan Linh, van der Heijden, Michiel S, Aerts, Hugo J W L, Beets-Tan, Regina G H

“…Immune checkpoint inhibitor efficacy in advanced cancer patients remains difficult to predict. Imaging is the only technique available that can non-invasively…”
Get full text

In situ characterisation of PEM water electrolysers using a novel reference electrode by Brightman, Edward, Dodwell, James, van Dijk, Nick, Hinds, Gareth

“…Polymer electrolyte membrane water electrolysers (PEMWEs) are a promising technology for hydrogen production but catalyst degradation mechanisms are poorly…”
Get full text

Effect of airbrush type on sprayed platinum and platinum-cobalt catalyst inks: Benchmarking as PEMFC and performance in an electrochemical hydrogen pump by Arenas, Luis F., Hadjigeorgiou, Georgios, Jones, Simon, Van Dijk, Nick, Hodgson, David, Cruden, Andy, Ponce de León, Carlos

“…Proton-exchange membrane fuel cells and electrochemical hydrogen pumps are based on membrane electrode assemblies containing Pt catalysts. During their…”
Get full text

Clinical efficacy and biomarker analysis of pre-operative ipilimumab plus nivolumab in stage III urothelial cancer: The NABUCCO trial update by Stockem, Chantal, Gil Jimenez, Alberto, van Dorp, Jeroen, Van Dijk, Nick, van Montfoort, Maurits L, Alkemade, Maartje, Seignette, Iris M., Broeks, Annegien, Hooijberg, Erik, Brugman, Wim, Mertens, Laura, van Rhijn, Bas W.G., De Feijter, Jeantine M, van der Heijden, Toine, Mehra, Niven, Meijer, Richard P., Suelmann, Britt, Vis, Daniel J, Wessels, Lodewyk F.A., Van Der Heijden, Michiel Simon

“…4593 Background: In the NABUCCO trial, pre-operative ipilimumab (ipi) + nivolumab (nivo) was studied in patients (pts) with stage III (cT3-4aN0M0 or…”
Get full text

High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial by van Dorp, Jeroen, Pipinikas, Christodoulos, Suelmann, Britt B. M., Mehra, Niven, van Dijk, Nick, Marsico, Giovanni, van Montfoort, Maurits L., Hackinger, Sophie, Braaf, Linde M., Amarante, Tauanne, van Steenis, Charlaine, McLay, Kirsten, Daletzakis, Antonios, van den Broek, Daan, van de Kamp, Maaike W., Hendricksen, Kees, de Feijter, Jeantine M., Boellaard, Thierry N., Meijer, Richard P., van der Heijden, Antoine G., Rosenfeld, Nitzan, van Rhijn, Bas W. G., Jones, Greg, van der Heijden, Michiel S.

“…Cohort 1 of the phase 1B NABUCCO trial showed high pathological complete response (pCR) rates with preoperative ipilimumab plus nivolumab in stage III…”
Get full text

Stepping Forward with Exoskeletons: Team IHMC?s Design and Approach in the 2016 Cybathlon by Griffin, Robert, Cobb, Tyson, Craig, Travis, Daniel, Mark, van Dijk, Nick, Gines, Jeremy, Kramer, Koen, Shah, Shriya, Siebinga, Olger, Smith, Jesper, Neuhaus, Peter

“…Exoskeletons are a promising technology that enables individuals with mobility limitations to walk again. As the 2016 Cybathlon illustrated, however, the…”
Get full text

Stepping Forward with Exoskeletons: Team IHMC's Design and Approach in the 2016 Cybathlon by Griffin, Robert, Cobb, Tyson, Craig, Travis, Daniel, Mark, van Dijk, Nick, Gines, Jeremy, Kramer, Koen, Shah, Shriya, Siebinga, Olger, Smith, Jesper, Neuhaus, Peter

“…IEEE Robotics & Automation Magazine, Volume: 24, Issue 4, Dec. 2017 Exoskeletons are a promising technology that enables individuals with mobility limitations…”
Get full text

Reply to Alessia Cimadamore, Liang Cheng, Marina Scarpelli, et al’s Letter to the Editor re: Alfonso Gómez de Liaño Lista, Nick van Dijk, Guillermo de Velasco Oria de Rueda, et al. Clinical Outcome After Progressing to Frontline and Second-line Anti–PD-1/PD-L1 in Advanced Urothelial Cancer. Eur Urol 2020;77:269–76. Progression and Hyperprogression Versus Pseudoprogression: Morphologic Documentation by van Dijk, Nick, Gómez de Liaño Lista, Alfonso, Szabados, Bernadett, Powles, Thomas, van der Heijden, Michiel S.

Get full text